During the past decade, Basingstoke and North Hampshire Hospital, Hemophilia, Hemostasis and Thrombosis Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Basingstoke and North Hampshire Hospital, Hemophilia, Hemostasis and Thrombosis Center" #1 collaborator was "Laboratoire français de Fractionnement et de Biotechnologies" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Basingstoke and North Hampshire Hospital, Hemophilia, Hemostasis and Thrombosis Center" are "Hemophilia A With Inhibitors" (1 trials), "Hemophilia B With Inhibitors" (1 trials) and "Severe Haemophilia A" (1 trials). Many other conditions were trialed in "Basingstoke and North Hampshire Hospital, Hemophilia, Hemostasis and Thrombosis Center" in a lesser frequency.

Most popular intervention types in "Basingstoke and North Hampshire Hospital, Hemophilia, Hemostasis and Thrombosis Center" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Coagulation Factor VIIa (Recombinant)" (1 trials) and "Human-cl rhFVIII" (1 trials). Other intervention names were less common.

The vast majority of trials in "Basingstoke and North Hampshire Hospital, Hemophilia, Hemostasis and Thrombosis Center" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Basingstoke and North Hampshire Hospital, Hemophilia, Hemostasis and Thrombosis Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Basingstoke and North Hampshire Hospital, Hemophilia, Hemostasis and Thrombosis Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Basingstoke and North Hampshire Hospital, Hemophilia, Hemostasis and Thrombosis Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".